Expression pattern of the RAR alpha-PML fusion gene in acute promyelocytic leukemia

M Alcalay1, D Zangrilli, M Fagioli

  • 1Istituto Clinica Medica I, University of Perugia, Policlinico Monteluce, Italy.

Insights

Acute promyelocytic leukemia (APL) involves chimeric genes like PML-RAR alpha. This study details the diverse organization and expression of the RAR alpha-PML gene in APL patients, revealing varied mRNA junctions and fusion transcripts.

Area of Science:

  • Molecular Biology
  • Hematology
  • Genetics

Background:

  • Acute promyelocytic leukemia (APL) is characterized by a specific chromosomal translocation, t(15;17).
  • This translocation results in the formation of chimeric genes, primarily PML-RAR alpha, which is a known fusion protein in APL.
  • The reciprocal RAR alpha-PML gene is also formed, but its organization and expression patterns are less understood.

Purpose of the Study:

  • To investigate the molecular organization and expression patterns of the RAR alpha-PML gene in APL patients.
  • To characterize the heterogeneity of RAR alpha-PML transcripts associated with the t(15;17) translocation.
  • To identify different mRNA junctions and fusion transcript variants.

Main Methods:

  • Analysis of RAR alpha-PML gene organization and expression in a series of APL patients.
  • Identification and characterization of different RAR alpha-PML mRNA junctions.
  • Sequencing and analysis of fusion transcripts to determine the assembly of PML coding exons.

Main Results:

  • Two distinct RAR alpha-PML mRNA junctions were identified: RAR alpha exon 2/PML exon 4 and RAR alpha exon 2/PML exon 7.
  • These junctions result from breaks at different sites on chromosome 15, maintaining open reading frames.
  • Ten different RAR alpha-PML fusion transcripts were found, varying in the assembly of PML coding exons.
  • A RAR alpha-PML transcript was detected in most, but not all, APL patients studied.

Conclusions:

  • The RAR alpha-PML gene exhibits significant molecular heterogeneity in APL patients with the t(15;17) translocation.
  • Variations in mRNA junctions and fusion transcript assembly contribute to the molecular landscape of APL.
  • Understanding this heterogeneity is crucial for comprehending APL pathogenesis and potentially for targeted therapies.

Related Concept Videos